Claudia Fischbach

From Wikipedia, the free encyclopedia

Claudia Fischbach
Alma materUniversity of Regensburg
Harvard University
Scientific career
InstitutionsCornell University
Harvard University
ThesisAdipose tissue engineering development of a 3-D model system of adipogenesis. (2004)

Claudia Fischbach is a German bioengineer who is the Stanley Bryer 1946 Professor of Biomedical Engineering at Cornell University. She is Director of the Cornell Physical Sciences Oncology Center on the Physics of Cancer Metabolism.

Early life and education[edit]

Fischbach earned a master's degree in pharmacy from the Ludwig Maximilian University of Munich. She worked toward her doctorate in pharmaceutical technology at the University of Regensburg. She then moved to Harvard University, where she worked in tissue engineering.[1]

Research and career[edit]

In 2007, Fischbach joined Cornell University,[2] where she started using biomedical engineering to better understand how to treat cancer.[3] The progression of cancer is influenced by interactions with nearby cells and the extracellular matrix. Despite that, the majority of cancer studies do not replicate conditions outside of the body. Fischbach uses tissue engineering to design systems that let her lab model and investigate how these interactions influence tumor cells. She uses model systems to understand the biological strategies tumors adopt to modify bodily function, become more aggressive, and metastasize.[4]

Fischbach has extensively investigated the fundamental mechanisms that underpin breast cancer. For example, she showed that obesity can change the composition of breast tissue, which can promote disease progression.[5][6] Moreover, she was supported by the Human Frontier Science Program to study the impact of breast cancer on the material properties of bone.[7][8] She showed that exercise, which is often prescribed to prevent bone loss, could also help to protect people against metastatic cancer.[9] In addition, her research demonstrated that breast cancer can trigger distant bone growth, which could be a preemptive defense against metastasis.[10]

Awards and honors[edit]

Selected publications[edit]

References[edit]

  1. ^ a b "Claudia Fischbach". mooneylab.seas.harvard.edu. Retrieved 6 January 2023.
  2. ^ "Principal Investigator – THE FISCHBACH LAB". www.fischbachlab.org. Retrieved 6 January 2023.
  3. ^ "Research – THE FISCHBACH LAB". www.fischbachlab.org. Retrieved 6 January 2023.
  4. ^ "Claudia Fischbach | Cornell Engineering". www.engineering.cornell.edu. Retrieved 6 January 2023.
  5. ^ "Stiffer breast tissue in obese women promotes tumors". Cornell Chronicle. Retrieved 6 January 2023.
  6. ^ Ramanujan-Cornell, Krishna (25 August 2015). "Obesity makes breast tissue stiff and scarred". Futurity. Retrieved 6 January 2023.
  7. ^ "Study to focus on breast cancer's effect on bone composition". Cornell Chronicle. Retrieved 6 January 2023.
  8. ^ "Metastatic breast cancer affects bone mineral before spreading". Cornell Chronicle. Retrieved 6 January 2023.
  9. ^ "Exercise could reduce bone tumor growth". Cornell Chronicle. Retrieved 6 January 2023.
  10. ^ "Researchers link breast cancer and bone growth". Cornell Chronicle. Retrieved 6 January 2023.
  11. ^ "Stories by Claudia Fischbach". Scientific American. Retrieved 6 January 2023.
  12. ^ "Claudia Fischbach-Teschl Claudia Fischbach-Teschl, Ph.D. To be Inducted into Medical and Biological Engineering Elite - AIMBE". Retrieved 6 January 2023.
  13. ^ "Claudia Fischbach-Teschl, Ph.D. COF-1951 - AIMBE". Retrieved 6 January 2023.
  14. ^ "Prof. Dr. Claudia Fischbach-Teschl - Alexander von Humboldt-Stiftung".
  15. ^ "EPICC Awards honor faculty, staff exemplifying college's core values | Cornell Engineering". www.engineering.cornell.edu. Retrieved 6 January 2023.
  16. ^ "Claudia Fischbach-Teschl wins 2023 CMBE Momentum Award | Meinig School of Biomedical Engineering". www.bme.cornell.edu. Retrieved 6 January 2023.
  17. ^ "CMBE Momentum Award - Biomedical Engineering Society". www.bmes.org. Retrieved 6 January 2023.